H Langrová

522 total citations
49 papers, 402 citations indexed

About

H Langrová is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H Langrová has authored 49 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Ophthalmology, 21 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H Langrová's work include Retinal Development and Disorders (18 papers), Retinal Diseases and Treatments (17 papers) and Retinal Imaging and Analysis (14 papers). H Langrová is often cited by papers focused on Retinal Development and Disorders (18 papers), Retinal Diseases and Treatments (17 papers) and Retinal Imaging and Analysis (14 papers). H Langrová collaborates with scholars based in Czechia, Germany and Poland. H Langrová's co-authors include Eberhart Zrenner, Anne Kurtenbach, Eckart Apfelstedt-Sylla, Jan Studnička, M. Bláha, V. Bláha, E Rencová, Hendrik P. N. Scholl, Herbert Jägle and Carsten M. Pusch and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

H Langrová

45 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Langrová Czechia 13 200 194 114 100 67 49 402
Barbara Link Germany 11 110 0.6× 114 0.6× 123 1.1× 40 0.4× 65 1.0× 22 358
C. T. Langerhorst Netherlands 11 407 2.0× 213 1.1× 270 2.4× 156 1.6× 19 0.3× 17 713
Elisa E. Cornish Australia 12 383 1.9× 313 1.6× 230 2.0× 99 1.0× 20 0.3× 37 608
Rongdi Yuan China 12 141 0.7× 92 0.5× 67 0.6× 73 0.7× 13 0.2× 40 322
Deborah Villafranca‐Baughman Canada 7 131 0.7× 176 0.9× 60 0.5× 65 0.7× 11 0.2× 10 403
Betül Seher Uysal Türkiye 12 210 1.1× 80 0.4× 195 1.7× 53 0.5× 13 0.2× 36 438
C. Pérez-Rico Spain 13 236 1.2× 135 0.7× 154 1.4× 42 0.4× 39 0.6× 49 457
Elise Héon Canada 12 204 1.0× 272 1.4× 96 0.8× 44 0.4× 18 0.3× 15 466
S. Mayor Spain 7 226 1.1× 332 1.7× 38 0.3× 114 1.1× 7 0.1× 12 456
Ailin Liu China 7 96 0.5× 150 0.8× 86 0.8× 30 0.3× 18 0.3× 17 326

Countries citing papers authored by H Langrová

Since Specialization
Citations

This map shows the geographic impact of H Langrová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Langrová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Langrová more than expected).

Fields of papers citing papers by H Langrová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Langrová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Langrová. The network helps show where H Langrová may publish in the future.

Co-authorship network of co-authors of H Langrová

This figure shows the co-authorship network connecting the top 25 collaborators of H Langrová. A scholar is included among the top collaborators of H Langrová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Langrová. H Langrová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bláha, V., Jana Rathouska, H Langrová, et al.. (2024). Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration. Scientific Reports. 14(1). 28902–28902. 1 indexed citations
2.
Langrová, H, et al.. (2023). Rheohemapheresis in the Treatment of Dry Form of AMD. A Case Report. PubMed. 79(1). 42–46. 1 indexed citations
3.
Stingl, Krunoslav, Katarína Štingl, Katarzyna Nowomiejska, et al.. (2020). Clinical Protocols for the Evaluation of Rod Function. Ophthalmologica. 244(5). 396–407. 13 indexed citations
4.
Straßer, Torsten, Anne Kurtenbach, H Langrová, Laura Kuehlewein, & Eberhart Zrenner. (2020). The perception threshold of the panda illusion, a particular form of 2D pulse-width-modulated halftone, correlates with visual acuity. Scientific Reports. 10(1). 13095–13095. 1 indexed citations
5.
Straßer, Torsten, Fadi Nasser, H Langrová, et al.. (2019). Objective assessment of visual acuity: a refined model for analyzing the sweep VEP. Documenta Ophthalmologica. 138(2). 97–116. 13 indexed citations
6.
Straßer, Torsten, H Langrová, Laura Kuehlewein, et al.. (2017). THEY CAN DISAPPEAR - Can the panda illusion be used to test visual acuity?. Investigative Ophthalmology & Visual Science. 58(8). 4216–4216.
7.
Kurtenbach, Anne, Christoph Kernstock, Eberhart Zrenner, & H Langrová. (2015). Electrophysiology and colour: a comparison of methods to evaluate inner retinal function. Documenta Ophthalmologica. 131(3). 159–167. 7 indexed citations
8.
Bláha, M., E Rencová, H Langrová, et al.. (2013). Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration. Atherosclerosis Supplements. 14(1). 179–184. 21 indexed citations
9.
Kurtenbach, Anne, H Langrová, André Messias, Eberhart Zrenner, & Herbert Jägle. (2012). A comparison of the performance of three visual evoked potential-based methods to estimate visual acuity. Documenta Ophthalmologica. 126(1). 45–56. 35 indexed citations
10.
Bláha, M., Jiří Piťha, V. Bláha, et al.. (2011). Experience with extracorporeal elimination therapy in myasthenia gravis. Transfusion and Apheresis Science. 45(3). 251–256. 4 indexed citations
11.
Kurtenbach, Anne, Thomas Dietrich, Eberhart Zrenner, & H Langrová. (2010). Topographical alterations of inner retinal activity during systemic hyperoxia–hypercapnia in normal subjects and patients with type 1 diabetes. Documenta Ophthalmologica. 120(3). 229–241. 1 indexed citations
12.
Rencová, E, M. Bláha, Jan Studnička, et al.. (2010). Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form. Acta Ophthalmologica. 89(5). 463–471. 19 indexed citations
13.
Langrová, H, Herbert Jägle, Eberhart Zrenner, & Anne Kurtenbach. (2007). The multifocal pattern electroretinogram (mfPERG) and cone-isolating stimuli. Visual Neuroscience. 24(6). 805–816. 9 indexed citations
14.
Langrová, H, et al.. (2003). Changes of Visual Function and Visual Ability in Daily Life Following Cataract Surgery. Acta Medica (Hradec Kralove Czech Republic). 46(4). 189–194. 3 indexed citations
15.
Jacobi, Frank, Sten Andréasson, H Langrová, et al.. (2002). Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene. Graefe s Archive for Clinical and Experimental Ophthalmology. 240(10). 822–828. 17 indexed citations
16.
Langrová, H, et al.. (2002). Abnormalities of the long flash ERG in congenital stationary night blindness of the Schubert–Bornschein type. Vision Research. 42(11). 1475–1483. 23 indexed citations
17.
Scholl, Hendrik P. N., H Langrová, Bernhard H. F. Weber, Eberhart Zrenner, & E Apfelstedt-Sylla. (2001). Clinical electrophysiology of two rod pathways: normative values and clinical application. Graefe s Archive for Clinical and Experimental Ophthalmology. 239(2). 71–80. 18 indexed citations
18.
Langrová, H, et al.. (1997). Visual Functions in Aphakia After Secondary Intraocular Lens Implantation. Acta Medica (Hradec Kralove Czech Republic). 40(3). 75–78.
19.
Langrová, H, et al.. (1997). Visual Functions After Photorefractive Keratectomy. Acta Medica (Hradec Kralove Czech Republic). 40(2). 47–49. 1 indexed citations
20.
Langrová, H, et al.. (1997). Unusual Ocular Findings in Children's Acute Leukemia Cases. Acta Medica (Hradec Kralove Czech Republic). 40(2). 51–56. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Link Breakdown of academic impact, for papers by C. T. Langerhorst Breakdown of academic impact, for papers by Elisa E. Cornish Breakdown of academic impact, for papers by Rongdi Yuan Breakdown of academic impact, for papers by Deborah Villafranca‐Baughman Breakdown of academic impact, for papers by Betül Seher Uysal Breakdown of academic impact, for papers by C. Pérez-Rico Breakdown of academic impact, for papers by Elise Héon Breakdown of academic impact, for papers by S. Mayor Breakdown of academic impact, for papers by Ailin Liu
Rankless by CCL
2026